Microbix Biosystems Inc.
MBXBF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $42 | $59 | $56 | $46 |
| - Cash | $12 | $15 | $13 | $13 |
| + Debt | $6 | $5 | $6 | $6 |
| Enterprise Value | $36 | $50 | $49 | $40 |
| Revenue | $3 | $5 | $6 | $6 |
| % Growth | -34.8% | -11.9% | -4% | – |
| Gross Profit | $1 | $3 | $4 | $3 |
| % Margin | 40.8% | 59.5% | 62.1% | 54.8% |
| EBITDA | -$1 | $1 | $2 | $1 |
| % Margin | -28% | 13.1% | 25.2% | 19.4% |
| Net Income | -$2 | $0 | $1 | $0 |
| % Margin | -47.3% | 0.4% | 14.2% | 7% |
| EPS Diluted | -0.012 | 0 | 0.006 | 0.003 |
| % Growth | -12,100% | -98.4% | 93.7% | – |
| Operating Cash Flow | -$2 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$2 | $1 | $1 | $1 |